J. Molner Investor Relations Material
Latest events
H2 2024
28 Mar, 2025
H1 2024
17 Sep, 2024
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from J. Molner AS
Access all reports
J. Molner AS is a pharmaceutical company based in Tallinn, Estonia, specializing in the development and provision of generic drugs, particularly sterile injectable and dermatology formulations. The company serves pharmaceutical markets in the United States, Canada, and Europe. In addition to drug development, J. Molner AS offers analytical chemistry services, European market release support, and ongoing stability solutions for its clients. The company is headquartered in Tallinn, Estonia, and its shares are listed on the Nasdaq Tallinn.
Latest articles
)
MSCI: Indexing the World
The story of how MSCI has become the backbone of global finance through its indexes, powering decision-making across trillions in assets.
30 May 2025
)
A Purpose-Built AI Chat for Finance and IR Professionals
Quartr Pro's new AI chat lets IR and finance professionals ask anything across 13,000+ public companies and get instant answers.
27 May 2025
)
Costco Wholesale: The Model of Scalable Simplicity
Costco's rise from warehouse club to retail giant is built on low prices, scale efficiency, and a model designed for lasting customer value.
26 May 2025
Ticker symbol
MOLNR
Country
🇪🇪 Estonia